A

ATRA

ATRA

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
10%Bearish
Buy/Sell Ratio62% buys
BearishBullish
ATRA Live QuoteReal-time
$6.77
$2.39(-26.09%)1M
Day Range$6.46 – $6.92
Open$6.56
Previous Close$6.50
Volume15.3K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$66.84M
P/E Ratio (TTM)24.5
Forward P/E14.4
EPS (TTM)$-1.12
Price to Book16.1
Dividend Yield0.65%
Beta (Volatility)0.32
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $6.77 (19%)
Low: $3.92High: $19.14
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$13.67-90.9% upside

Insider Buys

4

$6.60M

Insider Sales

19

$4.03M

Total Volume

$10.63M

36 transactions

Net Activity

+$2.57M

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
78CONFIDENCE

Sentiment Rating

Moderate Accumulation

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Moderate accumulation: purchases represent 62% of total transaction value.
  • •Cluster buying: 3 unique insiders purchased shares, showing strong alignment.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
  • •High accumulation: total purchase value exceeds $1M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

P - Purchase Insiders

0 buys13 sells

$120.72B total

E
2

Ecor1 Capital, LLC

10%

1 buys0 sells

$4.74M total

P
3

Panacea Innovation Ltd

10%

2 buys2 sells

$4.51M total

C
4

Cherry Brian N

Dir

1 buys0 sells

$1000K total

N
5

Nguyen Anhco

Pres, CEO

0 buys8 sells

$241K total

Trading History
ATRA insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Sep 4, 2026

2 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell166.5K$104166.00$17.34B

Sep 4, 2026

2 months ago

Cherry Brian N

Dir

Director
Buy104.2K$9.60$1000K

Aug 17, 2026

3 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell132.8K$-5062.00$0

Aug 17, 2026

3 months ago

Nguyen Anhco

Pres, CEO

CEO
Sell5.1K$8.08$41K

May 18, 2026

6 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell137.8K$-5241.00$0

May 18, 2026

6 months ago

Grant-Huerta Yanina

Chief Accounting Officer

C-Level
Sell2.4K$9.13$22K

May 18, 2026

6 months ago

Nguyen Anhco

Pres, CEO

CEO
Sell5.2K$9.13$48K

May 7, 2026

6 months ago

Ecor1 Capital, LLC

10%

10% Owner
Buy507.4K$9.35$4.74M

May 7, 2026

6 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell1.32M$-313446.00$0

May 7, 2026

6 months ago

Panacea Innovation Ltd

10%

10% Owner
Sell313.4K$10.10$3.17M

Mar 2, 2026

8 months ago

Nguyen Anhco

Pres, CEO

CEO
Sell3.0K$5.09$15K

Mar 2, 2026

8 months ago

Grant-Huerta Yanina

Chief Accounting Officer

C-Level
Sell2.1K$5.08$11K

Mar 2, 2026

8 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell31.8K$-2104.00$0

Jan 12, 2026

10 months ago

Panacea Innovation Ltd

10%

10% Owner
Sell80.6K$6.07$489K

Jan 12, 2026

10 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell1.37M$-80554.00$0

Nov 17, 2025

12 months ago

Nguyen Anhco

Pres, CEO

CEO
Sell2.9K$13.19$38K

Nov 17, 2025

12 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell65.0K$-2915.00$0

Nov 17, 2025

12 months ago

Grant-Huerta Yanina

Chief Accounting Officer

C-Level
Sell1.8K$13.19$24K

Aug 18, 2025

15 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell67.9K$-2958.00$0

Aug 18, 2025

15 months ago

Grant-Huerta Yanina

Chief Accounting Officer

C-Level
Sell1.8K$11.61$21K

Aug 18, 2025

15 months ago

Nguyen Anhco

Pres, CEO

CEO
Sell3.0K$11.62$34K

Aug 15, 2025

15 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.41M$55000.00$77.28B

Aug 15, 2025

15 months ago

Panacea Innovation Ltd

10%

10% Owner
Buy55.0K$12.19$670K

Jul 17, 2025

16 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.35M$19335.00$26.10B

Jul 17, 2025

16 months ago

Panacea Innovation Ltd

10%

10% Owner
Buy19.3K$9.64$186K

May 16, 2025

18 months ago

Grant-Huerta Yanina

Chief Accounting Officer

C-Level
Sell2.2K$6.76$15K

May 16, 2025

18 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell37.1K$-2218.00$0

May 16, 2025

18 months ago

Nguyen Anhco

Pres, CEO

CEO
Sell3.3K$6.76$22K

Mar 3, 2025

20 months ago

Henrich Jill

EVP, Chief Regulatory Officer

EVP
Sell1.1K$7.00$7K

Mar 3, 2025

20 months ago

Hyllengren Eric J

EVP, CFO, COO

CFO
Sell1.2K$7.00$8K

Mar 3, 2025

20 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell74.1K$-3331.00$0

Mar 3, 2025

20 months ago

Nguyen Anhco

Pres, CEO

CEO
Sell3.3K$7.00$23K

Nov 18, 2024

24 months ago

Nguyen Anhco

Pres, CEO

CEO
Sell1.7K$11.20$19K

Nov 18, 2024

24 months ago

Henrich Jill

EVP, Chief Regulatory Officer

EVP
Sell1.0K$11.20$11K

Nov 18, 2024

24 months ago

Hyllengren Eric J

EVP, CFO, COO

CFO
Sell1.4K$11.20$15K

Nov 18, 2024

24 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell19.4K$-1000.00$0
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
ATRA Buy Conviction62%
Industry Rank#0 of 563
Volume Contribution0.1%
Total Industry Activity$16.73B

ATRA has an insider buy conviction of 62%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for ATRA

Over the last 90 days, corporate insiders at ATRA (ATRA) engaged in a total of 36 transactions reported via SEC Form 4 filings. Among these, 4 were open-market purchases and 19 were sales. The total volume of insider trading reached $10.63M.

The net insider activity for ATRA shows a net buying bias of $2.57M. This activity represents a 62% buy ratio, suggesting that insiders are currently neutral on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 1.41M shares valued at $77.28B on Aug 15, 2025.

Live Market News & Developments
Aggregated real-time headlines for ATRA (ATRA)
6 updates

ATRA Stock Shoots Up 82% in a Month: Here's What You Should Know

Yahoo Finance182d ago

Tax withholding triggered an automatic sale of 6,094 shares for Atara Biotherapeutics (ATRA) CEO AnhCo Nguyen.

Stock Titan19h ago

ATRA - Atara Biotherapeutics Inc Stock Price and Quote

Finviz176d ago

Atara Biotherapeutics CEO AnhCo Nguyen sells $39,368 in stock By Investing.com

Investing.com UK12h ago

Should I buy Atara Biotherapeutics (ATRA)

Zacks Investment Research182d ago

ATRA Forecast — Price Target — Prediction for 2027

TradingView147d ago

FAQs About ATRA Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for ATRA.

Based on SEC Form 4 disclosures, the Insider Confidence Score for ATRA is currently 78/100, which reflects a moderate accumulation bias. This calculation accounts for a total of 4 purchases and 19 sales by company executives over the last 90 days.

The CEO Conviction Index for ATRA is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.